![Robert Redfield](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 166 322 $ as of 31/05/2026
Robert Redfield is the founder of Prevention Diagnosis Treatment, Inc. President & Chief Executive Officer at R3 Enterprises & Consulting.
Director at Viriom, Inc. Senior Strategic Officer at Pasaca Capital, Inc. from 2021 to 2022.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Traws Pharma, Inc.
 Traws Pharma, Inc. BiotechnologyHealth Technology Discovers and develops products for patients with cancer 0.75% | 08/03/2026 | 1,13,919 ( 0.75% ) | 166 322 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
Viriom, Inc.
 Viriom, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Pasaca Capital, Inc.
 Pasaca Capital, Inc. Investment ManagersFinance Pasaca Capital invests in companies located in the United States. The firm focuses on a finance, government, IT and manufacturing sectors. It provides financing for growth capital requirements. | Corporate Officer/Principal | 01/01/2022 |
Active
Inactive
Listed companies
Private companies
| Private companies | 2 |
|---|---|
Viriom, Inc.
Viriom, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Pasaca Capital, Inc.
Pasaca Capital, Inc. Investment ManagersFinance Pasaca Capital invests in companies located in the United States. The firm focuses on a finance, government, IT and manufacturing sectors. It provides financing for growth capital requirements. | Finance |
Select your edition
All financial news and data tailored to specific country editions
